MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from short term
loan payable, other
$488,198
Proceeds from private
offering issuance -...
$295,000
Proceeds from
convertible note and...
$250,000
Proceeds from private
offering issuance
$100,000
Net cash provided by
financing activities
$313,955
Canceled cashflow
$819,243
Increase (decrease) in
cash
$47,399
Canceled cashflow
$266,556
something is missing
-$374,029
Payments on short term
loan payable, other
$341,739
Payment on note payable
$103,475
something is missing
$6,158,489
Accounts payable -
related party
$263,061
Accrued liabilities
$185,672
Accounts payable
$132,051
Non-cash lease expense
$85,373
Employee and director
equity-based compensation
$26,959
Accounts receivable
-$2,211
Fair value
adjustment - convertible...
$1,754
Net cash (used in)
operating activities
-$266,556
Canceled cashflow
$6,855,570
Net loss
$6,884,474
Prepaid expenses
$133,388
Lease liabilities
-$84,899
Customer deposits
-$19,364
Other expenses
related to...
-$1
Back
Back
Cash Flow
source: myfinsight.com
Zivo Bioscience, Inc. (ZIVOW)
Zivo Bioscience, Inc. (ZIVOW)